20272 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing heavy metals Platinum compounds
Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
#1202Methods of Treating Cancer with High Potency Lipid-Based Platinum Compound Formulations Administered Intravenously
#1203Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
#1204Local treatment of neurofibromas
#1205Methods for attenuating virus strains for diagnostic and therapeutic uses
#1206Combinations and modes of administration of therapeutic agents and combination therapy
#1207COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
#1208Anti-tumor composition
#1209Coordination Compound Composed of Diaminocyclohexane Platinum (II) and Block Copolymer and Anti-Cancer Agent Comprising the Same
#1210METHOD OF TREATING CANCER BY ADMINISTRATION OF 5-SUBSTITUTED NUCLEOSIDES
#1211Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#1212Treatment with Anti-VEGF Antibodies
#1213USE OF 5-PHOSPHODIESTERASE INHIBITORS TO ENHANCE THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER OF ABNORMAL BRAIN TISSUE AND THE BLOOD-TUMOR BARRIER
#1214Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane
#1215Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
#1216TREATMENT WITH ANTI-VEGF ANTIBODIES
#1217TREATMENT WITH ANTI-VEGF ANTIBODIES
#1218SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION
#1219SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION
#1220KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF AN ERP57 PROTEIN TO A CELLULAR MEMBRANE
#1221Inhibitors of pyruvate kinase as therapeutic agents for cancer
#1222Metal-polysaccharide conjugates: compositions, synthesis and methods for cancer therapy
#1223Treatment of cancer with specific RXR agonists
#1224TREATMENT WITH ANTI-VEGF ANTIBODIES
#1225TREATMENT WITH ANTI-VEGF ANTIBODIES
#1226KINESIN INHIBITORS
#1227Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods
#1228TELOMERE TARGETING AGENTS AS STEM CELLS DIRECTED TREATMENTS
#1229Treatment With Anti-VEGF Antibodies
#1230LYOPHILIZED FORMULATION
#1231TREATMENT WITH ANTI-VEGF ANTIBODIES
#1232Methods and compositions for contributing to the treatment of cancers
#1233TREATMENT WITH ANTI-VEGF ANTIBODIES
#1234TREATMENT WITH ANTI-VEGF ANTIBODIES
#1235Advanced drug delivery strategy and platform for minimally-invasive treatment of liver cancer
#1236Indibulin therapy
#1237TARGETED ACTIVE AGENT DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES
#1238TREATMENT WITH ANTI-VEGF ANTIBODIES
#1239Composition having antitumor effect
#1240Combination Therapies Using Hdac Inhibitors
#1241Plastic Bottle for Oxaliplatin Solution
#1242Combination Therapy with Angiogenesis Inhibitors
#1243Method For Carrying Therapeutic Substances Into Cells
#1244Methods and Compositions for Treating Cancer Using BCL-2 Antisense Oligomers, Tyrosine Kinase Inhibitors, and Chemotherapeutic Agents
#1245TREATMENT WITH ANTI-VEGF ANTIBODIES
#1246TREATMENT WITH ANTI-VEGF ANTIBODIES
#1247Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy
#1248Microparticle preparation and medical composition
#1249Cross-linked ionic core micelles
#1250Antitumor Agent
#1251Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
#1252Methods and Compositions for Treating Tumors
#1253Process for treating a biological organism
#1254Device for packaging an oxaliplatin solution
#1255MOLECULAR MARKERS FOR DETERMINING TAXANE RESPONSIVENESS
#1256Prevention of Cell Proliferation by Inhibiting Myosin Light Chain Kinase
#1257COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS
#1258Combination chemotherapy compositions and methods
#1259Methods and compositions for treating proliferative diseases
#1260Methods For Treating Resistant Or Refractory Tumors
#1261Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer
#1262Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action
#1263Combination Chemotherapy Comprising Capecitabine and a Liposomal Platinum Complex
#1264Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium
#1265Pharmaceutical Composition for Rectal, or Vaginal Application, Method of Manufacturing and Use as Medicament Thereof
#1266Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
#1267Stable aqueous formulation of a platin derivative
#1268Compositions for delivery of drug combinations
#1269Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof
#1270Compositions useful for reducing nephrotoxicity and methods of use thereof
#1271Treatment with anti-VEGF antibodies
#1272Indole and Azaindole Derivatives with Antitumor Action
#1273Pharmaceutical Compositions Containing Platinum Complexes with Secondary Xanthates and Therapeutic Uses Thereof
#1274Liposome
#1275Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof
#1276TFIIS and GDOWN1 as targets for cancer therapy
#1277Nucleic acid carriers for delivery of therapeutic agents
#1278Novel Compositions And Methods Of Treatment
#1279Method Of Therapy
#1280Combination therapy for hyperproliferative disease
#1281Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
#1282Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
#1283Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
#1284Methods for suppressing an immune response or treating a proliferative disorder
#1285Combinations and modes of administration of therapeutic agents and combination therapy
#1286TREATMENT WITH ANTI-VEGF ANTIBODIES
#1287OXALIPLATIN FORMULATIONS
#1288TREATMENT WITH ANTI-VEGF ANTIBODIES
#1289Compositions for delivery of drug combinations
#1290TREATMENT WITH ANTI-VEGF ANTIBODIES
#1291TREATMENT WITH ANTI-VEGF ANTIBODIES
#1292Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
#1293Combined use of ecteinascidin-743 and platinum antineoplastic compounds
#1294Platinum IV complex inhibitor
#1295Surface marker-directed cancer therapeutics
#1296Safe and effective methods of administering therapeutic agents
#1297Imatinib combinations for head and neck cancers
#1298Methods and compositions for treating proliferative diseases
#1299Water-soluble stabilized self-assembled polyelectrolytes
#1300Cancer chemotherapy compositions comprising PI3K pathways modulators and triptolide
#1301Oligonucleotide analogues incorporating 5-aza-cytosine therein
#1302TREATMENT WITH ANTI-VEGF ANTIBODIES
#1303TREATMENT WITH ANTI-VEGF ANTIBODIES
#1304TREATMENT WITH ANTI-VEGF ANTIBODIES
#1305Therapeutic curcumin derivatives
#1306Stable oxaliplatin formulation
#1307Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
#1308Pharmaceutical composition comprising oxoplatin, the salts and derivatives thereof
#1309Stimulation of cellular regeneration and differentiation in the inner ear
#1310TREATMENT WITH ANTI-VEGF ANTIBODIES
#1311TREATMENT WITH ANTI-VEGF ANTIBODIES
#1312TREATMENT WITH ANTI-VEGF ANTIBODIES
#1313TREATMENT WITH ANTI-VEGF ANTIBODIES
#1314METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS
#1315TREATMENT WITH ANTI-VEGF ANTIBODIES
#1316Compositions and methods for facilitating reaction at room temperature
#1317TREATMENT WITH ANTI-VEGF ANTIBODIES
#1318System and method for the treatment of cancer, including cancers of the central nervous system
#1319Method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists
#1320STAT3 decoy oligonucleotides and uses therefor
#1321Method for the treatment of cancer using a novel pharmaceutical composition containing at least one dolastatin 10 derivative
#1322Pharmaceutical composition, method of manufacturing and therapeutic use thereof
#1323Agent for treatment of cisplatin-resistant cancer
#1324Acid containing oxaliplatin formulations
#1325Combinations and modes of administration of therapeutic agents and combination therapy
#1326Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
#1327Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
#1328Liposome compositions
#1329Stable pharmaceutical compositions of platinum (II) antitumour agents
#1330Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
#1331Methods and compositions for treating cancer
#1332Platinum therapeutic combinations
#1333Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
#1334Treatment with anti-ErbB2 antibodies and chemotherapeutic agents
#1335Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies
#1336Combination chemotherapy compositions and methods
#1337Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-]pyrimidines
#1338Administration of a thiol-based chemoprotectant compound
#1339Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
#1340Amplification of biotin-mediated targeting
#1341Oxaliplatin anti-resistance agent
#1342Combination of chemotherapeutic drugs for increasing antitumor activity
#1343Chroman derivatives, medicaments and use in therapy
#1344Therapeutic combinations comprising poly (ADP-ribose) polymerases inhibitor
#1345Treatment with anti-ErbB2 antibodies and anti-hormonal compounds
#1346Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
#1347SNS-595 and methods of using the same
#1348Method of treating ischemia-reperfusion injury
#1349Treatment with anti-ErbB2 antibody combinations
#1350Combination therapies for cancer and proliferative angiopathies
#1351SNS-595 and methods of using the same
#1352Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
#1353Method of treating breast cancer using a combination of vitamin D analogues and other agents
#1354Anti-tumor composition
#1355Combination comprising a CDK inhibitor and cisplatin
#1356Administration of cisplatin by inhalation
#1357Water-soluble stabilized self-assembled polyelectrolytes
#1358Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
#1359Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
#1360Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
#1361Methods of using SNS-595
#1362Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
#1363Treatment with anti-VEGF antibodies
#1364Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination
#1365Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
#1366Treatment of cancers by inhalation of stable platinum-containing formulations
#1367Method of treating cancer using dithiocarbamate derivatives
#1368Compositions and methods for topically treating diseases
#1369Oxaliplatin formulations
#1370Radiotherapy method using x-rays
#1371Coumarin derivative
#1372Combinations of drugs for the treatment of neoplasms
#1373Methods for the prevention and treatment of hearing loss using Oseltamivir
#1374Antibodies targeting CD40 and uses thereof
#1375Antibodies specific to CD40 and uses thereof
#1376Anti-CD40 antibodies and uses thereof
#1377CD40 binding antibodies and uses thereof
#1378CD40 specific antibodies and uses thereof
#1379Method for administering cisplatin and a thiocyanate complex to treat ovarian cancer
#1380Pharmaceutical composition containing a cisplatin and platinum thiocyanate combination
#1381Antibodies binding CD40 and uses thereof
#1382Antibodies binding OX40 and uses thereof
#1383Antibodies binding human Claudin 18.2 and uses thereof
#1384Synthesis, x-ray structures and cytotoxic behavior of platinum (II) complexes of dithiocarbamates
#1385Method for inhibiting cancer cell growth with a transplatin complex
#1386Transplatin derivatives as anticancer agents